This site is intended for UK Healthcare professionals only

Are you a UK Healthcare professional?

We are unfortunately unable to allow patients to attend DPC

If you would like more information on diabetes care, please refer to the NHS website.

Visit the NHS website?

Forxiga (Dapagliflozin): Whose Drug is it Anyway?



An AstraZeneca live promotional webinar
Monday 20th September - 19:00 - 20:30

Click here for prescribing information and AE reporting.


This promotional AstraZeneca webinar is for HCPs in Great Britain only and has been organised and funded by AstraZeneca.
DPC are responsible for hosting and marketing this webinar.

We are pleased to invite you to attend a very exciting, live webinar on 20th September from 19:00 – 20:30, organised by AstraZeneca in collaboration with DPC. The live panel webinar will bring together experts from primary and secondary care to discuss the latest data relating to FORXIGA 10mg in chronic kidney disease, regardless of Type 2 diabetes status.


DR JANAKA KARALLIEDDE, Consultant Diabetologist Guy’s and St Thomas’ Hospital London and Clinical Reader in Diabetes and Cardiovascular Disease, King's College London
PROF DAVID WHEELER, Co-chief investigator of the Dapa-CKD trial, Professor of Kidney Medicine, UCL, London
PROF INDRANIL DASGUPTA, Professor Nephrologist at Heartlands Hospital Birmingham, Co-Chair Joint ABCD UKKA Committee
DR WAQAS TAHIR, Diabetes Lead at Bradford



Info box

banner agenda

CKD - Chronic Kidney Disease
HFrEF - Heart Failure with reduced ejection fraction
SGLT2i - sodium glucose co-transporter-2 inhibitors
T2D - Type 2 diabetes


Diamond Sponsor

  • AstraZeneca


Platinum Sponsor

  • Novo Nordisk


Platinum Sponsor

  • Viatris


Platinum Sponsor

  • Abbott


Gold Sponsor

  • BI & Lilly Alliance


Gold Sponsor

  • Roche


Gold Sponsor

  • Lilly


Gold Sponsor

  • BI


Gold Sponsor

  • Insulet


Silver Sponsor

  • Ascensia


Registration Sponsor

  • Diabetes Research & Wellness Foundation


Official Event App Sponsor

  • Napp